PYXS Pyxis Oncology, Inc.
Healthcare · Pharmaceutical Preparations · Market cap: $189.0M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $5.3M |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $5.0M | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $73.5K | $81.4K |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $174.4K | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $15.9K |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $107.1K |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $0 |
Bought$5.5M11 buy days
Sold$5.5M10 sell days
Net insider flow+$12.8Knet buying · 5 years
Latest trade2026-06-30Dupont Jakob
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Sell | Dupont Jakob | Director | 35,000 | $3.06 | $107.1K | 1 |
| 2025-04-21 | Sell | HUMPHREY RACHEL | Director | 13,896 | $1.03 | $14.3K | 1 |
| 2025-04-17 | Sell | HUMPHREY RACHEL | Director | 200 | $0.97 | $194 | 1 |
| 2025-04-14 | Sell | HUMPHREY RACHEL | Director | 1,400 | $0.97 | $1.4K | 1 |
| 2024-11-26 | Buy | Connealy Pamela Ann | CFO | 88,850 | $1.96 | $174.4K | 2 |
| 2023-09-28 | Buy | Connealy Pamela Ann | CFO | 8,000 | $1.87 | $15.0K | 1 |
| 2023-09-27 | Buy | Connealy Pamela Ann | CFO | 6,426 | $1.85 | $11.9K | 1 |
| 2023-09-27 | Buy | Wadhane Jitendra | Other C-suite | 2,500 | $1.87 | $4.7K | 1 |
| 2023-09-25 | Buy | Connealy Pamela Ann | CFO | 12,000 | $1.67 | $20.0K | 1 |
| 2023-09-25 | Buy | Wadhane Jitendra | Other C-suite | 5,000 | $1.77 | $8.8K | 1 |
| 2023-09-22 | Buy | Connealy Pamela Ann | CFO | 5,000 | $1.74 | $8.7K | 1 |
| 2023-09-22 | Buy | Wadhane Jitendra | Other C-suite | 2,500 | $1.74 | $4.4K | 1 |
| 2023-09-18 | Sell | Sullivan Lara | CEO | 8,541 | $2.10 | $17.9K | 1 |
| 2023-09-14 | Sell | Sullivan Lara | CEO | 100 | $2.25 | $225 | 1 |
| 2023-09-13 | Sell | Sullivan Lara | CEO | 3,000 | $2.27 | $6.8K | 1 |
| 2023-09-12 | Sell | Sullivan Lara | CEO | 4,917 | $2.25 | $11.1K | 1 |
| 2023-09-11 | Sell | Sullivan Lara | CEO | 20,000 | $2.27 | $45.4K | 1 |
| 2023-03-17 | Buy | PFIZER INC | 10% owner | 1,811,594 | $2.76 | $5.0M | 1 |
| 2022-04-21 | Sell | Chin Mark | Other | 1,745,761 | $3.05 | $5.3M | 1 |
| 2021-12-08 | Buy | Cline Darren S | Director | 10,000 | $9.39 | $93.9K | 1 |
| 2021-11-18 | Buy | Civik Thomas | Director | 15,700 | $12.74 | $200.0K | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Chin Mark | Other | $0 | $5.3M | 2022-04-21 |
| PFIZER INC | 10% owner | $5.0M | $0 | 2023-03-17 |
| Connealy Pamela Ann | CFO | $230.0K | $0 | 2024-11-26 |
| Civik Thomas | Director | $200.0K | $0 | 2021-11-18 |
| Dupont Jakob | Director | $0 | $107.1K | 2026-06-30 |
| Cline Darren S | Director | $93.9K | $0 | 2021-12-08 |
| Sullivan Lara | CEO | $0 | $81.4K | 2023-09-18 |
| Wadhane Jitendra | Other C-suite | $17.9K | $0 | 2023-09-27 |
| HUMPHREY RACHEL | Director | $0 | $15.9K | 2025-04-21 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
No buying cluster has formed at this company.
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.